MDMA ("ecstasy") and neurotoxicity.
Mithoefer
Michael
M
Jerome
Lisa
L
Doblin
Richard
R
D000818:Animals; D001921:Brain / Q000187:drug effects* / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism*; D050483:Dopamine Plasma Membrane Transport Proteins; D006213:Hallucinogens / Q000008:administration & dosage / Q000009:adverse effects / Q000633:toxicity*; D000882:Haplorhini; D006801:Humans; D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins / Q000378:metabolism; D018817:N-Methyl-3,4-methylenedioxyamphetamine / Q000008:administration & dosage / Q000009:adverse effects / Q000633:toxicity*; D009419:Nerve Tissue Proteins; D009474:Neurons / Q000187:drug effects* / Q000378:metabolism; D020734:Parkinsonian Disorders / Q000139:chemically induced
D050483:Dopamine Plasma Membrane Transport Proteins; D006213:Hallucinogens; D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins; D009419:Nerve Tissue Proteins; D018817:N-Methyl-3,4-methylenedioxyamphetamine; D004298:Dopamine